Lorriana Leard, MD is an Associate Professor of Clinical Medicine and a board-certified pulmonologist who specializes in the care of patients with lung cancer and advanced lung diseases who are candidates for lung transplants. As an expert at the UCSF Helen Diller Family Comprehensive Cancer Center, she evaluates patients who have lung nodules, lung masses or symptoms suggestive of lung cancer, and she helped to establish the Lung Cancer Screening Program at UCSF. She also performs advanced bronchoscopic procedures, including Endobronchial Ultrasound (EBUS), tracheobronchial dilatation, tracheal and bronchial stent placement, transbronchial needle aspiration and biopsies, and gold fiducial placement in preparation for Cyberknife therapy.
Dr. Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco and joined the faculty in 2006.
Her major academic interests include Lung Transplantation, Interventional Bronchoscopy, and Lung Cancer. She cares for patients on the Lung Transplant service, and at the UCSF Helen Diller Comprehensive Cancer Center at Mt. Zion.
UCSF Lung Cancer Screening Program offers same day low-dose CT scan and consultation with a pulmonologist. The process of being screened for lung cancer is explained in this video by Dr. Lorriana Leard
Awards & Honors
Award
Confired By  
Date  
V. Courtney Broaddus Award for Leadership and Service
UCSF
2022
Academy of Medical Educators
UCSF
2011
Michael S. Stulbarg Outstanding Teaching Award
UCSF
2007
Research Overview
Dr. Leard's current research interests include (1) Assessment of the role of Donor Specific Antibodies in the development of Bronchiolitis obliterans, (2) Bronchoscopy Complications, and (3) Lung Cancer Screening.
Santos J, Wang P, Shemesh A, Liu F, Tsao T, Aguilar OA, Cleary SJ, Singer JP, Gao Y, Hays SR, Golden J, Leard LE, Kleinhenz ME, Kolaitis NA, Shah RJ, Venado A, Kukreja J, Weigt SS, Belperio JA, Lanier LL, Looney MR, Greenland JR, Calabrese DR. CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury. JCI Insight. 2023 Oct 03. View in PubMed
Santos J, Hays SR, Golden JA, Calabrese DR, Kolaitis N, Kleinhenz ME, Shah R, Estrada AV, Leard LE, Kukreja J, Singer JP, Greenland JR. Decreased Lymphocytic Bronchitis Severity in the Era of Azithromycin Prophylaxis. Transplant Direct. 2023 Sep; 9(9):e1495. View in PubMed
Singer JP, Christie JD, Diamond JM, Anderson MA, Benvenuto LA, Gao Y, Arcasoy SM, Lederer DJ, Calabrese D, Wang P, Hays SR, Kukreja J, Venado A, Kolaitis NA, Leard LE, Shah RJ, Kleinhenz ME, Golden J, Betancourt L, Oyster M, Zaleski D, Adler J, Kalman L, Balar P, Patel S, Medikonda N, Koons B, Tevald M, Covinsky KE, Greenland JR, Katz PK. Development of the Lung Transplant Frailty Scale (LT-FS). J Heart Lung Transplant. 2023 Jul; 42(7):892-904. View in PubMed
Odisho AY, Liu AW, Maiorano AR, Bigazzi MOA, Medina E, Leard LE, Shah R, Venado A, Perez A, Golden J, Kleinhenz ME, Kolaitis NA, Maheshwari J, Trinh BN, Kukreja J, Greenland J, Calabrese D, Neinstein AB, Singer JP, Hays SR. Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function. J Heart Lung Transplant. 2023 06; 42(6):828-837. View in PubMed
Calabrese DR, Chong T, Singer JP, Rajalingam R, Hays SR, Kukreja J, Leard L, Golden JA, Lanier LL, Greenland JR. CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction. Am J Transplant. 2023 01; 23(1):37-44. View in PubMed